HempMeds®, HempMeds® Mexico and HempMeds® Brasil Announce July 2019 as the Largest Sales Bookings Month in Company History

We’re in High Demand! HempMeds®, including our operations in the U.S., Mexico and Brazil, had our largest-ever (unaudited) sales bookings month in our Company’s history in July 2019.

This growth is a part of a current larger trend in overall cannabis and cannabidiol (CBD) market expansion. Leading cannabis researchers at BDS Analytics and Arcview Market Research project that the collective market for CBD sales in the U.S. will surpass $20 billion by 2024.

“HempMeds is a large part of our strategy in being a Company of Firsts,” said Medical Marijuana, Inc. CEO Dr. Stuart Titus. “While many know that HempMeds is the first distributor of CBD hemp oil products in the U.S., HempMeds also received the first-ever federal government approvals to import CBD products into both Mexico and Brazil. Since receiving those historic approvals, we have been excited and humbled to watch large new foreign markets develop and to lead the way with HempMeds Mexico and HempMeds Brasil.”

HempMeds Personal Care Line of CBD Products

HempMeds® has achieved significant accomplishments recently including securing over 100 new retail partners, expanding its CBD-infused Personal Care Line for skin and hair, and launching its Everyday Wellness Line of functional CBD supplements for digestive, sleep and immune support. HempMeds® Brasil also recently hosted its third series of cannabinoid medicine courses in São Paulo to educate doctors in the country about the many possible uses for CBD.

“We’ve been hard at work further innovating our brand offerings and are seeing great results by driving home the HempMeds promise to be your trusted CBD source. This fundamentally guides our commitment to develop innovative, highest-quality and effective natural products,” said HempMeds® President Todd Morrow. “We have many exciting announcements slated for the second half of the year and hope to broaden our customer base significantly with more new product announcements and retail partnerships.”

Accomplishments also include HempMeds® obtaining positive news coverage in several national and international news outlets including Benzinga, Medium, San Francisco Chronicle, Trend Hunter, Drugstore News, The National Marijuana News, Parade Magazine, and many more.

About HempMeds®
HempMeds® is a corporate portfolio company of Medical Marijuana, Inc. (OTC:MJNA) and the Company’s exclusive master distributor and contracted marketing company, handling sales and distribution.

Read the full press release here: https://www.nasdaq.com/press-release/medical-marijuana-inc-subsidiaries-hempmeds-hempmeds-mexico-and-hempmeds-brasil-announce-july-2019-20190806-00652

Recommended Posts

HempMeds® Featured in CFN Media Report on the Boom... HempMeds® was mentioned in an article by CFN Media covering a recent cannabis industry report by Brightfield Group. In an article this week covering ...
RaulWHO Part 2: Why HempMeds? #RaulWHO Why HempMeds®? If you haven’t already heard the great news, our HempMeds® Mexico President Raul Elizalde will be speaking at the U.N. &...
HempMeds® CEO Speaks at Autism Tree Event HempMeds® very own CEO Dr. Stuart Titus spoke on the CBD oil panel at the Autism Tree Project Foundation’s 3rd Annual Neuroscience Conference, held at...
RaulWHO Part 3: WHY HEMP OIL Last week we introduced you to Raul Elizalde, President of HempMeds® Mexico and founder of the Por Grace Foundation. Raul’s efforts on behalf of me...


There are no products